Cite
The toronto observational study of natalizumab in multiple sclerosis.
MLA
Krysko, Kristen M., and Paul W. O’Connor. “The Toronto Observational Study of Natalizumab in Multiple Sclerosis.” The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, vol. 38, no. 3, May 2011, pp. 422–28. EBSCOhost, https://doi.org/10.1017/s0317167100011811.
APA
Krysko, K. M., & O’Connor, P. W. (2011). The toronto observational study of natalizumab in multiple sclerosis. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques, 38(3), 422–428. https://doi.org/10.1017/s0317167100011811
Chicago
Krysko, Kristen M, and Paul W O’Connor. 2011. “The Toronto Observational Study of Natalizumab in Multiple Sclerosis.” The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques 38 (3): 422–28. doi:10.1017/s0317167100011811.